Table 9.

Measures of inflammatory markers

Variable	Day 0	Day 84	Within Group p-Value	Between Group p-Value
Human COMP (×100 ng/mL)
Placebo	4280.4 (±1037.8)	4577.8 (±1498.7)	0.195	0.091
AF1	4151.0 (±1186.6)	3818.9 (±1171.4)	0.092
AF2	4229.5 (±1339.9)	4303.0 (±1387.6)	0.700
AF1 + AF2	4191.7 (±1258.4)	4069.6 (±1296.4)	0.371
TNF-alpha (pg/mL)
Placebo	38.9 (±26.3)	37.2 (±22.2)	0.733	0.492
AF1	51.7 (±35.6)	49.5 (±37.3)	0.641
AF2	47.5 (±26.3)	39.4 (±25.5)	0.026
AF1 + AF2	49.5 (±30.1)	44.3 (±31.9)	0.074
C-Reactive Protein (mg/L)
Placebo	2.5 (±1.8)	1.7 (±1.5)	0.044	0.137
AF1	2.5 (±2.7)	2.5 (±3.1)	0.909
AF2	2.3 (±2.2)	2.0 (±1.9)	0.249
AF1 + AF2	2.3 (±2.4)	2.2 (±2.5)	0.619

Values Presented as Mean ± Standard Deviation

Values determined to be significant (p = <0.05) indicated